DIN 02501791 — AZACITIDINE FOR INJECTION 100 MG
AZACITIDINE FOR INJECTION is a powder for suspension of Azacitidine marketed by JAMP PHARMA CORPORATION. The full Azacitidine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02501791
- Brand name
- AZACITIDINE FOR INJECTION
- Active ingredient
- Azacitidine
- Strength
- 100 MG
- Dosage form
- POWDER FOR SUSPENSION
- Route
- SUBCUTANEOUS
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- DORMANT
- Drug class
- Pyrimidine nucleoside analogue / DNA hypomethylating agent (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Azacitidine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02462826 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02505177 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02507668 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | HIKMA CANADA LIMITED | MARKETED |
| 02529599 | AZACITIDINE FOR INJECTION | 100 MG | POWDER FOR SUSPENSION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02510197 | ONUREG | 200 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02510200 | ONUREG | 300 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02336707 | VIDAZA | 100 MG | POWDER FOR SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |